Literature DB >> 28149544

The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease.

Shu-Wu Zhao1, Yu-Ping Wang2, Lin-Dong Xu1, Wei Gang1.   

Abstract

BACKGROUND: This study aims to explore the application value of thromboelastogram (TEG) in antiplatelet therapy in coronary artery intervention.
METHODS: A retrospective analysis of 90 cases of coronary interventional treatment was conducted in our hospital from January 2010 to January 2012. Cases were divided into three groups, according to the kind of coronary heart disease: angina pectoris (AP) group (30 cases), unstable angina pectoris (UAP) group (30 cases) and acute myocardial infarction (AMI) group (30 cases). TEG changes in patients between the three groups were analyzed.
RESULTS: The differences in international normalized ratio (INR) and activated partial thromboplastin time (APTT) indexes among the three groups of patients were statistically significant (P<0.05), but these indexes significantly decreased in the AMI group. Furthermore, D-D, Fgb, Angle and MA indexes significantly increased in the UAP and AMI groups, compared with the AP group; while TEG regular parameter K and R values were markedly reduced. Coagulation graphics were higher in the UAP and AMI groups than in the AP group (χ2=4.261, 3.908; P<0.05), suggesting that the difference was statistically significant. In 11 cases of ischemic events, arachidonic acid (AA)-induced platelet inhibition rate was 63.63%, while adenosine diphosphate (ADP)-induced platelet inhibition rate was 36.37% (χ2=5.026; P<0.05); suggesting that ADP-induced platelet inhibition rate was markedly reduced. This is the main risk of ischemic events within three months after percutaneous coronary intervention.
CONCLUSIONS: The detection of indexes of antiplatelet therapy in coronary artery intervention is helpful for antiplatelet medication, thus can effectively reduce the incidence of ischemic events.

Entities:  

Keywords:  Thrombus elasticity; antiplatelet therapy; coronary intervention

Year:  2016        PMID: 28149544      PMCID: PMC5227287          DOI: 10.21037/jtd.2016.12.77

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  11 in total

Review 1.  Thrombelastography.

Authors:  Håkon Reikvam; Egil Steien; Bjørn Hauge; Knut Liseth; Kristin Gjerde Hagen; Rolf Størkson; Tor Hervig
Journal:  Transfus Apher Sci       Date:  2009-02-26       Impact factor: 1.764

Review 2.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

3.  The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.

Authors:  Chi Young Shim; Se-Jung Yoon; Sungha Park; Jung-Sun Kim; Jong Rak Choi; Young-Guk Ko; Donghoon Choi; Jong-Won Ha; Yangsoo Jang; Namsik Chung; Won-Heum Shim; Seung-Yun Cho
Journal:  Int J Cardiol       Date:  2008-06-24       Impact factor: 4.164

Review 4.  Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

Authors:  C Patrono; B Coller; J E Dalen; V Fuster; M Gent; L A Harker; J Hirsh; G Roth
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

5.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

6.  Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting.

Authors:  Antonino S Rubino; Alessandro Della Corte; Raffaele Giordano; Lorenzo Menicanti
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-11       Impact factor: 4.191

7.  Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.

Authors:  Udaya S Tantry; Kevin P Bliden; Paul A Gurbel
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

8.  Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients.

Authors:  Bryan A Cotton; Kristin M Minei; Zayde A Radwan; Nena Matijevic; Evan Pivalizza; Jeanette Podbielski; Charles E Wade; Rosemary A Kozar; John B Holcomb
Journal:  J Trauma Acute Care Surg       Date:  2012-06       Impact factor: 3.313

Review 9.  Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance.

Authors:  Marco Cattaneo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-23       Impact factor: 8.311

10.  Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention.

Authors:  Kozo Hoshino; Hisanori Horiuchi; Tomohisa Tada; Junichi Tazaki; Eiichiro Nishi; Mitsunori Kawato; Tomoyuki Ikeda; Hiromi Yamamoto; Masaharu Akao; Yutaka Furukawa; Satoshi Shizuta; Masanao Toma; Toshihiro Tamura; Naritatsu Saito; Takahiro Doi; Neiko Ozasa; Toshikazu Jinnai; Kanako Takahashi; Haruyo Watanabe; Yuka Yoshikawa; Naoko Nishimoto; Chiho Ouchi; Takeshi Morimoto; Toru Kita; Takeshi Kimura
Journal:  Circ J       Date:  2008-12-24       Impact factor: 2.993

View more
  2 in total

1.  Influence of Lower Extremity Deep Venous Thrombosis in Cerebral Infarction on Coagulation Index and Thromboelastogram and Its Risk Factors.

Authors:  Tao Jin; Lingkai Jiang; Xiaolei Zhang
Journal:  J Healthc Eng       Date:  2022-01-06       Impact factor: 2.682

2.  Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention.

Authors:  Bangming Cao; Fuzheng Qu; Xianliang Liu; Changzheng Gao; Qiang Fu; Chunying Jiang; Peng Wei; Qianqian Ma
Journal:  Aging (Albany NY)       Date:  2019-10-30       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.